Beyond neurotransmitters: why psychiatry must restore life, not just silence symptoms
Original title: #404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn’t enough, and the future of psychedelic therapies | Linus Abrams, M.D.
Contemporary psychiatry has built its success on the premise of symptom reduction, yet this metric ignores a deeper goal: the full restoration of human experience that makes life worth living. Linus Abrams challenges the dominant neurobiological model by introducing the critical role of hormonal systems in mental health, a territory historically sidelined in conventional psychiatric training. This hormonal lens explains why patients achieving symptom remission through psychopharmaceuticals often report anhedonia, emotional flatness, or a «blank» life that current protocols leave untouched. The therapeutic future, according to Abrams, integrates traditional pharmacology with emerging psychedelic therapies, which appear to activate neuroplastic restoration beyond simple neurotransmitter reuptake. For the longevity-oriented reader, this means reframing mental health not as disease absence, but as capacity for full experience, connection, and purpose—metrics requiring simultaneous endocrine and psychological evaluation.
Editorial summary by LongevityMap. For the full article and references, visit Peter Attia Drive.
More from Longevity Daily
- Peter Attia Drive•
Metabolic liver health: reversible when caught and treated early
- Peter Attia Drive•
Gum recession: the silent deterioration your own habits may be accelerating
- Peter Attia Drive•
Multifactorial trials: what they prove and what they don't
- Peter Attia Drive•
Peptides: why scientific rigor matters more than ever